Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2013

VistaGen Therapeutics, Inc. (VSTA) Taps Key Research Institutions to Achieve Strategic Objectives

California-based VistaGen Therapeutics, a biotechnology company applying proprietary human pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, has been highly effective in pro-actively partnering with important academic and government research institutions to help the company … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

GlobalWise Investments, Inc. (GWIV) to Present at Technology United Executive Conference alongside Fortune 500 Companies

GlobalWise Investments and its wholly owned subsidiary Intellinetics, a leading-edge technology company focused on the design, implementation, and management of cloud-based Enterprise Content Management (“ECM”) systems, reported today that William J. “BJ” Santiago, CEO of GlobalWise, will be speaking at … Continue reading

Posted in GlobalWise Investments Inc. GWIV | Leave a comment

Quantum Fuel Systems (QTWW) Receives $600,000 in New Orders for Natural Gas Storage Tanks for Light Duty Vehicles

Natural gas, alternative fuel systems and clean propulsion vehicle technologies leader Quantum Fuel Systems Technologies Worldwide has announced the receipt of purchase orders from new and existing customers amounting to around $600,000 for its ultra-lightweight Q-Lite compressed natural gas (CNG) … Continue reading

Posted in Small Cap News | Leave a comment

Jonathan B. Lloyd Jones Joins Columbia Laboratories, Inc. (CBRX) as VP-Finance, CFO, Treasurer, and Secretary

Yesterday, Columbia Laboratories announced that Jonathan B. Lloyd Jones, ACA, MBA has been appointed as the company’s Vice President-Finance, Chief Financial Officer, Treasurer, and Secretary, effective January 21. Mr. Jones will be based at Columbia’s corporate headquarters, which will be … Continue reading

Posted in Small Cap News | Leave a comment

Chimera Investment Corp. (CIM) Video Chart for Wednesday, January 16, 2013

CIM has broken through strong resistance in the area of $2.70. That old resistance has been tested once as a support level since the breakout. With new highs recently hit, this chart is on watch for continued upward pressure. To … Continue reading

Posted in Technical Analysis | Leave a comment

Echelon Corp. (ELON) and ELO Announce Completion of Eletrobas Advanced Sensor & Smart Meter Project in Brazil

Echelon Corp., the premier energy control networking solution provider worldwide, and ELO Sistemas Eletronicos, one of the largest meter manufacturers in Brazil, announced that the Parintins City Project, ELO’s deployment of a 3,400 unit pilot installation with Eletrobras, is nearing … Continue reading

Posted in Small Cap News | Leave a comment

Universal Power Group, Inc. (UPG) Announces Agreement to Acquire Kinetik Brand

Universal Power Group, a Texas-based distributor and supplier of batteries and related power accessories, yesterday announced that the company has entered into an agreement to acquire the brands, trademarks, and intellectual property of Kinetik, an industry leader in power for … Continue reading

Posted in Small Cap News | Leave a comment

Synthesis Energy Systems, Inc. (SYMX) Agrees to Conduct Study on Applying Gasification Technology to Produce Green Chemicals

Synthesis Energy reported entry today into an agreement with an undisclosed U.S.-based firm aimed at determining the best strategies for implementing the company’s own proprietary gasification technology, U-GAS®, for producing so-called ‘green’ chemicals from waste and landfill feedstocks. The financial … Continue reading

Posted in Small Cap News | Leave a comment

Galectin Therapeutics, Inc. (GALT) Names New Executive Director of Regulatory Affairs and Quality Assurance

Galectin Therapeutics is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer. The therapies are based on the company’s unique understanding of galectin proteins, which are key mediators of biological and pathologic functions. The company reported … Continue reading

Posted in Small Cap News | Leave a comment

Neuralstem, Inc. (CUR) Receives FDA OK to Begin Phase I Trials

Neuralstem announced that it had received approval from the FDA to begin Phase I safety trials of NSI-566. NSI-566 is a cell therapy candidate; the main goal of the study is to determine the safety and toxicity of human spinal … Continue reading

Posted in Small Cap News | Leave a comment